This explainer video is a short animation that illustrates the immune processes of Multiple Sclerosis in relation to the gut microbiome and how that plays a role in disease progression.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 0.25 credits
MOC types
No MOC
FDA REMS
No
Qualifies for MIPS
No
Pricing
68% of listed courses are free
39 of 57 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Child & Adolescent Psychiatry
- Clinical Informatics
- Critical Care Medicine
- Emergency Medicine
- Family Medicine
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Pediatrics
- Health Equity & Inclusion
- Hospice & Palliative Medicine
- Infectious Disease
- Medical Oncology
- Mood & Anxiety Disorders
- Neurodevelopmental Disabilities
- Neurology
- Neuroradiology
- Obstetric Anesthesia
- Pain Medicine
- Patient Safety & Quality Improvement
- Pediatric Emergency Medicine
- Practice Management & Ethics
- Psychotic Disorders
- Pulmonary Disease
- Urological Oncology
- Anesthesiology
- Cross-Specialty
- Emergency & Critical Care
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Urology
- No reviews yet. Be the first to share yours.
- On-demand / recorded video
- Credit · Up to 0.25 credits
-
ReleasedJun 4, 2025
-
Last day to claim creditJun 4, 2028 2 years left
-
Des Moines University Integrating Clinical Insight and Innovation in the Management of Multiple Sclerosis
-
PRIME Education, Inc. (PRIME®) Collaborative Approaches to Detecting and Addressing Silent Disease Progression in Multiple Sclerosis
-
PVI, PeerView Institute for Medical Education Neuroinflammation In Focus: Interpreting the Latest Evidence for BTK Inhibition in Multiple Sclerosis
